All patients were evaluated for tumour and node response using response evaluation criteria in solid tumour (RECIST) criteri, acute and late toxicities according to CTCAE version 3.0 (common terminology criteria for adverse events), RTOG / EORTC (Toxicity criteria of the Radiation Therapy Oncology Group / the European Organization for Research and Treatment of Cancer).
Tất cả các bệnh nhân đều được đánh giá kết quả đáp ứng u và hạch theo tiêu chí RECIST, đánh giá độc tính cấp theo CTCAE v 3.0 (criteria and toxicities according to common terminology criteria for adverse events) và độc tính muộn theo RTOG / EORTC (Toxicity criteria of the Radiation Therapy Oncology Group / the European Organization for Research and Treatment of Cancer).